产品编号 | bs-47152P-Bio |
英文名称 | Recombinant human MICA protein, C-His-Avi (HEK293), Biotin conjugated |
中文名称 | 生物素标记重组人MICA蛋白 |
别 名 | FLJ60820; MGC111087; MICA; PERB11.1; Stress inducible class I homolog; MHC class I polypeptide-related sequence A, isoform CRA_c; Q96QC4_HUMAN; Recombinant human MICA protein, C-His-Avi (HEK293) / Biotin |
克 隆 号 | |
理论分子量 | 35.8 kDa |
检测分子量 | Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result. |
浓 度 | >0.5 mg/ml |
纯 度 | >95% as determined by Tris-Bis PAGE; >95% as determined by SEC-HPLC |
缓 冲 液 | Lyophilized from 0.22um filtered solution in PBS (pH7.4) with 5mM DTT. Normally 5% trehalose is added as protectant before Lyophilization. |
保存条件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
产品介绍 |
The MHC class I chain-related (MIC) proteins are related to the Major histocompatibility complex (MHC) class I proteins which are ubiquitously expressed and mediate the recognition of intracellular antigens by cytotoxic T cells. The MHC class I chain-related (MIC) proteins are recognized by NKG2D, a receptor on NK and T cells, and promote anti-tumor activity. MICA, a member of the MIC family, is widely expressed on many tumors, and it is the MICA/NKG2D interaction that is thought to stimulate the anti-tumor reactivity by T lymphocytes. MICA is present in virtually every tissue except the nervous system, suggesting that MIC protein expression may only be one component of the anti-tumor activity of the immune system. MICA蛋白是一种细胞应激分子,在正常组织中表达量少,仅在肠道上皮组织表达量稍高,但是在多种肿瘤细胞,尤其是上皮源性的肿瘤如肺癌、乳腺癌、肾癌、卵巢癌、结肠癌等细胞表面高表达,并在细胞发生癌变的早期阶段出现在细胞表面。 该分子与相应受体NKG2D结合后可激活NK细胞、Vd1 gd T细胞、CD8+ T细胞的细胞毒作用,从而产生杀伤肿瘤细胞的生物效应。因此,抗MICA特异性抗体在肿瘤早期诊断、治疗中可能具有更高的敏感性和疗效,从而可实现肿瘤的“早诊断、早治疗”。并且还能对其它治疗方案的疗效进行早期评估。 |
产品图片 |
The purity of Biotinylated Recombinant human MICA Protein is greater than 95% as determined by SEC-HPLC.
|
1、抗体溶解方法 | |
2、抗体修复方式 | |
3、常用试剂的配制 | |
4、免疫组化操作步骤 | |
5、免疫组化问题解答 | |
6、Western Blotting 操作步骤 | |
7、Western Blotting 问题解答 | |
8、关于肽链的设计 | |
9、多肽的溶解与保存 | |
10、酶标抗体效价测定程序 | |